drugset / Trial / NCT01668862

A Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate in Lateral Epicondylitis (Tennis Elbow)

NCT01668862 ↗

Phase 1/2 Unknown 20 enrolled Kasiak Research Pvt. Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of human Platelet Lysate (HPL) in subjects with Lateral Epicondylitis (Tennis Elbow). The study is being conducted in 2 centers in India. The primary end points are Visual Analog Score (VAS) and Patient rated tennis elbow evaluation (PRTEE) score. The secondary endpoint is improvement in ultrasonography form randomization to End of study.

Timeline

Start
2012-03
Primary completion
2012-10
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Human Platelet Lysate Other / unclassified — Other

Indications